Taysha Gene Therapies
Signal active
Organization
Contact Information
Overview
Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system. Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications.
About
Industries
Biotechnology, Life Science, Genetics
Founded
2020
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Taysha Gene Therapies headquartered in United States, North America, operates in the Biotechnology, Life Science, Genetics sector. The company focuses on Biotechnology and has secured $52.1B in funding across 96 round(s). With a team of 51-100 employees, Taysha Gene Therapies is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Taysha Gene Therapies, raised $75.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
Funding Rounds
Funding rounds
8
Investors
0
Lead Investors
0
Total Funding Amount
$543.0M
Details
2
Taysha Gene Therapies has raised a total of $543.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 30.0M | ||
| 2020 | Early Stage Venture | 95.0M |
Investors
Taysha Gene Therapies is funded by 44 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Taysha Gene Therapies | - | FUNDING ROUND - Taysha Gene Therapies | 150.0M |
| Kynam Capital Management | - | FUNDING ROUND - Kynam Capital Management | 150.0M |
| Taysha Gene Therapies | - | FUNDING ROUND - Taysha Gene Therapies | 40.0M |
| Trinity Capital | - | FUNDING ROUND - Trinity Capital | 40.0M |
Recent Activity
There is no recent news or activity for this profile.